Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cells.


Journal

Cellular immunology
ISSN: 1090-2163
Titre abrégé: Cell Immunol
Pays: Netherlands
ID NLM: 1246405

Informations de publication

Date de publication:
03 2020
Historique:
received: 27 11 2019
revised: 18 01 2020
accepted: 25 01 2020
pubmed: 6 2 2020
medline: 18 8 2020
entrez: 5 2 2020
Statut: ppublish

Résumé

NFAT2 activity was shown to be of critical importance in B cell receptor signaling, development and proliferation; however its role in B cell development in the periphery is still not completely understood. We confirmed that NFAT2 deletion leads to impaired B1 B cell development, supported by our finding of limited B1 progenitors in the bone marrow and spleen of NFAT2 deficient mice. Moreover, we show for the first time that loss of NFAT2 increases immature B cells in particular transitional T2 and T3 as well as mature follicular B cells while marginal zone B cells are decreased. We further demonstrate that NFAT2 regulates the expression of B220, CD23, CD38, IgM/IgD and ZAP70 in murine B cells. In vivo analyses revealed decreased proliferation and increased apoptosis of NFAT2 deficient B cells. In summary, this study provides an extensive analysis of the role of NFAT2 in peripheral B lymphocyte development.

Identifiants

pubmed: 32014271
pii: S0008-8749(19)30505-2
doi: 10.1016/j.cellimm.2020.104048
pii:
doi:

Substances chimiques

Antigens, Differentiation, B-Lymphocyte 0
Immunoglobulin D 0
Immunoglobulin M 0
NFATC Transcription Factors 0
Nfatc1 protein, mouse 0
Leukocyte Common Antigens EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104048

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Melanie Märklin (M)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany. Electronic address: melanie.maerklin@med.uni-tuebingen.de.

Jonas S Heitmann (JS)

Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany.

Joseph Kauer (J)

University of Tübingen, Interfaculty Institute for Cell Biology, Dept. of Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.

Stefan Wirths (S)

Dept. of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany.

Martin R Müller (MR)

Dept. of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany; Dept. of Hematology, Oncology and Immunology, Klinikum Region Hannover, KRH Klinikum Siloah, Hannover, Germany. Electronic address: martin.mueller@krh.eu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH